203 related articles for article (PubMed ID: 4723533)
1. Effects of immunosuppression on coxsackie B-3 virus infection in mice, and passive protection by circulating antibody.
Rager-Zisman B; Allison AC
J Gen Virol; 1973 Jun; 19(3):339-51. PubMed ID: 4723533
[No Abstract] [Full Text] [Related]
2. The role of antibody and host cells in the resistance of mice against infection by coxsackie B-3 virus.
Rager-Zisman B; Allison AC
J Gen Virol; 1973 Jun; 19(3):329-38. PubMed ID: 4353212
[No Abstract] [Full Text] [Related]
3. Involvement of T lymphocytes in the pathogenesis of coxsackie virus B3 heart disease.
Woodruff JF; Woodruff JJ
J Immunol; 1974 Dec; 113(6):1726-34. PubMed ID: 4610045
[No Abstract] [Full Text] [Related]
4. Modification of severe coxsackievirus B 3 infection in marasmic mice by transfer of immune lymphoid cells.
Woodruff JF; Woodruff JJ
Proc Natl Acad Sci U S A; 1971 Sep; 68(9):2108-11. PubMed ID: 5289370
[TBL] [Abstract][Full Text] [Related]
5. [Diabetogenic properties of Coxsackie A13 and Coxsackie B4 viruses in experimental infection in mice].
Bocharov EF; Shorin IuP; Solodovnikova IA; Kazarian LS; Seliatitskaia VG
Vopr Virusol; 1988; 33(4):469-74. PubMed ID: 2848368
[TBL] [Abstract][Full Text] [Related]
6. [Experimental study of Coxsackie-streptococcal infection].
Kogut EP; Levashova NV; Bondarenko AP; Zherdeva AI; Shuvalova IA
Vopr Virusol; 1978; (6):690-5. PubMed ID: 219625
[TBL] [Abstract][Full Text] [Related]
7. Experimental coxackievirus B 1 infection in immunologically altered mice.
Petrovicová A
J Hyg Epidemiol Microbiol Immunol; 1983; 27(2):149-54. PubMed ID: 6309957
[TBL] [Abstract][Full Text] [Related]
8. [Heart disorder due to Coxsackie viruses B].
Moravcová J; Ledec J; Kopecká D
Vnitr Lek; 1973 Jul; 19(7):660-5. PubMed ID: 4726016
[No Abstract] [Full Text] [Related]
9. The influence of different temperatures on mortality, virus multiplication and interferon production in adult mice infected with Coxsackie B1 virus.
Haahr S; Teisner B
Arch Gesamte Virusforsch; 1973; 42(3):273-7. PubMed ID: 4754181
[No Abstract] [Full Text] [Related]
10. [The antiviral properties of 4-iodoantipyrine in an experimental enterovirus infection].
Iavorovskaia VE; Gritsenko LN; Petrov SA; Evstropov AN
Vopr Virusol; 1994; 39(4):184-7. PubMed ID: 7998400
[TBL] [Abstract][Full Text] [Related]
11. Coxsackievirus infection of mice. II. Viral kinetics and histopathological changes in mice experimentally infected with coxsackievirus B3 by intraperitoneal route.
Vargová A; Bopegamage S; Borsanyiová M; Petrovicová A; Benkovicová M
Acta Virol; 2003; 47(4):253-7. PubMed ID: 15068381
[TBL] [Abstract][Full Text] [Related]
12. [Study of Coxsackie A 10 virus infection in newborn and suckling mice of the strains A2G, ICR-K and CBA].
Voiculescu C; Stanciu L; Rogoz S; Blaj-Băjeu S; Tomescu R; Tăţulescu M
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1980; 25(1):35-43. PubMed ID: 6154959
[TBL] [Abstract][Full Text] [Related]
13. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice.
Ku Z; Liu Q; Ye X; Cai Y; Wang X; Shi J; Li D; Jin X; An W; Huang Z
Vaccine; 2014 Jul; 32(34):4296-303. PubMed ID: 24950363
[TBL] [Abstract][Full Text] [Related]
14. Peroral infection with group B coxsackievirus in the adult mouse: protective functions of the gut.
Loria RM; Kibrick S; Broitman SA
J Infect Dis; 1974 Nov; 130(5):539-43. PubMed ID: 4423592
[No Abstract] [Full Text] [Related]
15. [Anti-Coxsakie B viruses humoral immunity status in patients with pancreatic diseases].
Trukhan DI
Vopr Virusol; 2001; 46(2):33-6. PubMed ID: 11392968
[TBL] [Abstract][Full Text] [Related]
16. [Immunity response of 3 animal species (guinea pigs, hamsters, mice) to various Coxsackie viruses of group A. II. Study of antibodies detected by gel immunodiffusion: comparison with complement fixing antibodies].
Bringuier JP; Gaudin OG; Brigaud M; Terraillon J; Sohier R
Ann Inst Pasteur (Paris); 1971 Oct; 121(4):551-61. PubMed ID: 5004043
[No Abstract] [Full Text] [Related]
17. Post-coxsackie virus B3 myocardiopathy in mice.
Feinstone SM; Hensley GT; Rytel MW
Proc Soc Exp Biol Med; 1973 Oct; 144(1):345-50. PubMed ID: 4589215
[No Abstract] [Full Text] [Related]
18. Experimental Coxsackie virus B-3 and B-4 myocarditis in mice.
Kawai C; Matsumori A; Kumagai N; Tokuda M
Jpn Circ J; 1978 Jan; 42(1):43-7. PubMed ID: 633597
[TBL] [Abstract][Full Text] [Related]
19. [Persistent infection caused by the Coxsackie B3 virus in adult mice].
Goriunova AG; Savinov AP
Vopr Virusol; 1987; 32(2):213-6. PubMed ID: 3037797
[TBL] [Abstract][Full Text] [Related]
20. Interferon and neutralizing antibody in sera of exercised mice with coxsackievirus B-3 myocarditis.
Reyes MP; Lerner AM
Proc Soc Exp Biol Med; 1976 Feb; 151(2):333-8. PubMed ID: 1250870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
